---
title: "Rein Therapeutics Inc. (RNTX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/RNTX.US.md"
symbol: "RNTX.US"
name: "Rein Therapeutics Inc."
industry: "生物技术"
---

# Rein Therapeutics Inc. (RNTX.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [www.reintx.com](https://www.reintx.com) |

## Company Profile

Rein Therapeutics Inc.是一家生物制药公司，专注于开发药物以满足美国孤儿肺病和纤维化适应症的未满足医疗需求。该公司的主要产品候选药物是 LTI-03，一种肽，目前正在进行特发性肺纤维化（IPF）的 1b 期临床试验。它还提供 LTI-01，这是一种前酶，已在 LPE 患者中完成 1b 期和 2a 期临床试验，用于治疗局部性胸腔积液。该公司的研发管线还包括针对囊性纤维化的临床前项目，以及一个针对洞蛋白-1 蛋白的肽项目，旨在治疗全身性纤维化适应症；以及 LTI-05，一种上皮钠通道，用于治疗囊性纤维化

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.53 | 147/604 | - | - | - |
| PB | 26.40 | 419/604 | 25.95 | 9.11 | 5.05 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-21T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 50% |
| Overweight | 0 | 0% |
| Hold | 1 | 50% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.19 |
| Highest Target | 10.00 |
| Lowest Target | 10.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/RNTX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/RNTX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/RNTX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.